The global blood warmer market is anticipated to grow at a considerable CAGR of 8.9% during the forecast period. The primary factor accelerating the growth of the market includes the rising number of chronic diseases such as cancer, tumor, arthritis, and others across the globe. During the treatment of these chronic diseases, blood and blood-related products are used which are stored at low temperatures to prevent them from decaying. Thus, during transfusion of red blood cells (RBCs) and platelets, among others, blood stored at low temperatures is warmed to normal temperature before transfusion by using blood warmer devices. According to the World Health Organization (WHO), in 2019, the prevalence of anemia patients was 29.9% in women aged between 15 to 49 years. Moreover, the problem of anemia in children was estimated at around 39.8%.
Browse the full report description of “Global Blood Warmer Market Size, Share & Trends Analysis Report by Product (Portable Blood Warmers and Non-Portable Blood Warmers), by Applications (Newborn Care, Preoperative Care, Acute Care, and Home Care), and by End-User (Hospitals/Clinic, Ambulatory Services, Defense Forces, and Rescue Forces) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/blood-warmer-market
Another factor accelerating the market growth is the rise in utilization of blood warmer devices during the COVID-19 pandemic. There was a significant rise in demand for infusion therapy owing to the increase in COVID-19 cases across the globe. Blood warmer devices are used to raise fluids to body temperature and provide speedy recovery while reducing the risk of transfusion shock. Post-COVID-19 pandemic, several market players started focusing on integrating next-generation technologies within the blood warmer devices to cater to the rising demand for the devices in hospitals and clinics. For instance, in July 2019, Baxter International Inc. launched TherMax blood warmer and PrisMax systems. The product launched includes next-generation technology for continuous renal replacement therapy. The product’s innovative technology simplifies therapy delivery and provides improved flexibility to the hospital’s ICU.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Product
o By Application
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- 3M Co., Geratherm Medical AG, Smiths Group plc, Stryker Corp, Vyaire Medical, Inc., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Blood Warmer Market Report Segment
By Product
By Applications
By End-User
Global Blood Warmer Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/blood-warmer-market